DarioHealth Corp.

For the period ended Sep 30, 2025. Filed Nov 13, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 13, 2025

DRIO$2.39+16.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited)


· · Three months ended · · Nine months ended
· · September 30, · · September 30,
	2025		2024		2025		2024
Revenues:
Services		$3,209		$5,604		$11,745		$14,424
Consumer hardware		1,798		1,819		5,383		5,012
Total revenues		5,007		7,423		17,128		19,436

Cost of revenues:
Services		613		920		2,299		2,845
Consumer hardware		1,198		1,282		3,479		3,786
Amortization of acquired intangible assets		181		1,344		1,489		3,740
Total cost of revenues		1,992		3,546		7,267		10,371

Gross profit		3,015		3,877		9,861		9,065

Operating expenses:
Research and development		$3,328		$5,446		$11,157		$18,898
Sales and marketing		4,604		6,733		15,708		20,775
General and administrative		4,567		3,728		11,089		15,468

Total operating expenses		12,499		15,907		37,954		55,141

Operating loss		9,484		12,030		28,093		46,076

Interest expenses		1,157		—		1,923		—
Other financial expenses (income), net		(175)		313		2,645		(10,954)

Total financial expenses (income), net		982		313		4,568		(10,954)

Loss before taxes		10,466		12,343		32,661		35,122

Income tax (benefit)		—		(13)		22		(2,007)

Net loss		$10,466		$12,330		$32,683		$33,115

Deemed dividend (contribution)		$8,389		$2,278		$18,800		$(4,394)

Net loss attributable to common shareholders		$18,855		$14,608		$51,483		$28,721

Net loss per share:

Basic and diluted loss per share of common stock		$2.96		$4.91		$9.05		$10.38
Weighted average number of common stock used in computing basic and diluted net loss per share**		3,138,106		2,020,872		2,673,794		1,954,679

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.